产品详情
所在位置: 首页> 产品目录> 试剂>
查看大图

  • 产品名称：RimonabantHCl

  • 产品型号：
  • 产品厂商：TargetMol
  • 产品文档：
你添加了1件商品 查看购物车
简单介绍：
RimonabantHCl
详情介绍：
Purpose Rimonabant is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. It is an inverse agonist for the cannabinoid receptor CB1. Its main avenue of effect is reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. Rimonabant is approved in 38 countries including the E.U., Mexico, and Brazil. It was rejected for approval for use in the United States. This decision was made after a U.S. advisory panel recommended the medicine not be approved because it may increase suicidal thinking and depression.
Characteristics Tradename: SR141716
Source of Compound: synthetic
Target: Cannabinoid Receptor antagonist
Receptor: Cannabinoid Receptor
Purification All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
Purity 98 %
Formula C22H21Cl3N4O
Solubility Soluble in DMSO
Molecular Weight 500.25 g/mol
CAS-No 158681-13-1
Application Notes Optimal working dilution should be determined by the investigator.
Restrictions For Research Use only
Format Solid
Storage -20 °C
Storage Comment For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
Several freeze/thaw cycles should not damage the activity of our small molecule products.
However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours.
Expiry Date 24 months